BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8764000)

  • 1. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production.
    Schols D; De Clercq E
    J Virol; 1996 Aug; 70(8):4953-60. PubMed ID: 8764000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA.
    Oyaizu N; Chirmule N; Kalyanaraman VS; Hall WW; Pahwa R; Shuster M; Pahwa S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2379-83. PubMed ID: 2315327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of the inhibitory effects of HIV-gp120 on CD4+ T cells by stimulation through the CD28 pathway.
    Faith A; Yssel H; O'Hehir RE; Lamb JR
    Clin Exp Immunol; 1996 Aug; 105(2):225-30. PubMed ID: 8706326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures.
    Bejarano MT; de Waal Malefyt R; Abrams JS; Bigler M; Bacchetta R; de Vries JE; Roncarolo MG
    Int Immunol; 1992 Dec; 4(12):1389-97. PubMed ID: 1286062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumour necrosis factor-alpha (TNF-alpha) in the induction of HIV-1 gp120-mediated CD4+ T cell anergy.
    Kaneko H; Hishikawa T; Sekigawa I; Hashimoto H; Okumura K; Kaneko Y
    Clin Exp Immunol; 1997 Jul; 109(1):41-6. PubMed ID: 9218822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells.
    Kawamura T; Gatanaga H; Borris DL; Connors M; Mitsuya H; Blauvelt A
    J Immunol; 2003 Apr; 170(8):4260-6. PubMed ID: 12682260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.
    Liegler TJ; Stites DP
    J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):340-8. PubMed ID: 7907660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity.
    Cavaleiro R; Sousa AE; Loureiro A; Victorino RM
    AIDS; 2000 Dec; 14(17):2679-86. PubMed ID: 11125886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans.
    Pietrella D; Kozel TR; Monari C; Bistoni F; Vecchiarelli A
    J Infect Dis; 2001 Jan; 183(1):51-8. PubMed ID: 11087201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide in the promoting effect of HIV type 1 infection and of gp120 envelope glycoprotein on interleukin 4-induced IgE production by normal human mononuclear cells.
    Dugas N; Dereuddre-Bosquet N; Goujard C; Dormont D; Tardieu M; Delfraissy JF
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):251-8. PubMed ID: 10710213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of HIV-1 gp120 molecule fragments with human monocytes: different requirements for tumor necrosis factor-alpha and IL-6 production.
    Zembala M; Pryjma J; Plucienniczak A; Szczepanek A; Jasinski M; Ruggiero I; Piselli P; Colizzi V
    Clin Immunol Immunopathol; 1995 May; 75(2):131-9. PubMed ID: 7704970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha.
    Karsten V; Gordon S; Kirn A; Herbein G
    Immunology; 1996 May; 88(1):55-60. PubMed ID: 8707350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
    Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
    Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.